Gestational trophoblastic disease (GTD) refers to a group of rare tumors that develop in the cells that would normally form the placenta during pregnancy. These tumors are not contagious and cannot be transmitted from one person to another.
GTD occurs when there is an abnormal growth of cells in the placenta, which can lead to the formation of tumors. There are two main types of GTD: hydatidiform mole (also known as a molar pregnancy) and gestational trophoblastic neoplasia (GTN). Hydatidiform mole is a non-cancerous tumor that forms in the uterus, while GTN is a malignant form of GTD that can spread to other parts of the body.
Hydatidiform mole is not contagious and does not pose a risk to others. It occurs due to an abnormal fertilization process, where the sperm fertilizes an empty egg or an egg with no genetic material. This results in the growth of abnormal placental tissue, which can lead to symptoms such as vaginal bleeding, enlarged uterus, and high levels of human chorionic gonadotropin (hCG) hormone.
Gestational trophoblastic neoplasia (GTN), on the other hand, is a malignant form of GTD that can spread to other parts of the body, including the lungs, liver, and brain. GTN can occur after a molar pregnancy or a normal pregnancy. It is important to note that while GTN is not contagious, it requires prompt medical treatment to prevent further spread and complications.
If you suspect you may have GTD or have been diagnosed with it, it is crucial to consult with a healthcare professional for proper diagnosis and treatment. Early detection and appropriate management can lead to successful outcomes and minimize potential complications.